← Back to Search

Telehealth Exercise for Lymphoma Survivors

N/A
Waitlist Available
Led By Kyuwan Lee
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 2-5 years after completing anti-cancer therapy with no evidence of disease
Aged 18 years or older
Must not have
Overt cardiovascular disease within 6 months (e.g. myocardial infarction, stroke, angina)
Female patients who are pregnant or planning to become pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether an at-home exercise program, done with the help of a care provider online, can help improve heart health in lymphoma survivors.

Who is the study for?
This trial is for adults over 18 who've had Hodgkin or non-Hodgkin lymphoma, are 2-5 years post-cancer therapy with no current disease, and have a moderate to high risk of heart issues. They must be able to exercise and not already doing structured workouts more than an hour weekly.
What is being tested?
The study tests a telehealth exercise program aimed at improving cardiovascular health in lymphoma survivors. Participants will do physical exercises at home guided online by healthcare providers to see if it reduces their risk of heart disease.
What are the potential side effects?
Since the intervention involves exercise, potential side effects may include typical workout-related issues like muscle soreness or strain. However, as this is not a drug trial, severe side effects are less likely compared to medication-based interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I finished my cancer treatment 2-5 years ago and currently show no signs of the disease.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with Hodgkin or non-Hodgkin lymphoma.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I haven't had a heart attack, stroke, or severe chest pain in the last 6 months.
Select...
I am pregnant or planning to become pregnant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to the telehealth exercise intervention
Secondary study objectives
Effects of an 8-week telehealth exercise intervention

Side effects data

From 2020 Phase 3 trial • 177 Patients • NCT01817075
13%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (telehealth exercise)Experimental Treatment2 Interventions
Patients participate in telehealth exercise intervention for 30 minutes per day, 3 days a week for 8 weeks.
Group II: Group II (delayed control)Active Control3 Interventions
Patients maintain current levels of physical activity for 8 weeks. Patients may then participate in telehealth exercise intervention for 8 weeks.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
602 Previous Clinical Trials
1,923,570 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,926 Previous Clinical Trials
41,018,031 Total Patients Enrolled
Kyuwan LeePrincipal InvestigatorCity of Hope Medical Center
2 Previous Clinical Trials
54 Total Patients Enrolled

Media Library

Telehealth Exercise Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05205512 — N/A
Non-Hodgkin's Lymphoma Research Study Groups: Group I (telehealth exercise), Group II (delayed control)
Non-Hodgkin's Lymphoma Clinical Trial 2023: Telehealth Exercise Intervention Highlights & Side Effects. Trial Name: NCT05205512 — N/A
Telehealth Exercise Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05205512 — N/A
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top